Please enable Javascript

Labmeeting uses lots of Javascript - basically you can't use the site without it. So please enable Javascript in your browser. If your browser does not support Javascript, we recommend Firefox.

Papers authored by Märten A

Collect these papers and discover other ones on Labmeeting. Learn more.

Erlotinib 150 mg daily plus chemotherapy in advanced pancreatic cancer: an interim safety analysis of a multicenter, randomized, cross-over phase III trial of the 'Arbeitsgemeinschaft Internistische Onkologie'.

+ cite this

+ View Abstract

Boeck S, Vehling-Kaiser U, Waldschmidt D, Kettner E, Märten A, Winkelmann C, Klein S, Kojouharoff G, Gauler T, Fischer von Weikersthal L, Clemens MR, Geissler M, Greten TF, Hegewisch-Becker S, Neugebauer S, and Heinemann V

Anti-cancer drugs 21(1):94-100, 2010 Jan - Who cited this? | PubMed ID: 19770635 | Fulltext

Soluble iC3b as an Early Marker for Pancreatic Adenocarcinoma Is Superior to CA19.9 and Radiology.

+ cite this

+ View Abstract

Märten A, Büchler MW, Werft W, Wente MN, Kirschfink M, and Schmidt J

Journal of immunotherapy (Hagerstown, Md. : 1997) 33(2):219-24, 2010 - Who cited this? | PubMed ID: 20139773 | Fulltext

Intracapillary leucocyte accumulation as a novel antihaemorrhagic mechanism in acute pancreatitis in mice.

+ cite this

+ View Abstract

Ryschich E, Kerkadze V, Deduchovas O, Salnikova O, Parseliunas A, Märten A, Hartwig W, Sperandio M, and Schmidt J

Gut 58(11):1508-16, 2009 Nov - Who cited this? | PubMed ID: 19460768 | Fulltext

Ex vivo expanded telomerase-specific T cells are effective in an orthotopic mouse model for pancreatic adenocarcinoma.

+ cite this

+ View Abstract

Hassanin H, Serba S, Schmidt J, and Märten A

Clinical and experimental immunology 158(1):125-32, 2009 Oct - Who cited this? | PubMed ID: 19737239 | Fulltext

Examination of external validity in randomized controlled trials for adjuvant treatment of pancreatic adenocarcinoma.

+ cite this

+ View Abstract

Sorg C, Schmidt J, Büchler MW, Edler L, and Märten A

Pancreas 38(5):542-50, 2009 Jul - Who cited this? | PubMed ID: 19287330 | Fulltext

Comparison of phenotype of gammadelta T cells generated using various cultivation methods.

+ cite this

+ View Abstract

Mehrle S, Watzl C, von Lilienfeld-Toal M, Amoroso A, Schmidt J, and Märten A

Immunology letters 125(1):53-8, 2009 Jun 30 - Who cited this? | PubMed ID: 19505505 | Fulltext

Cuticular Hydrocarbon Phenotypes Do not Indicate Cryptic Species in Fungus-Growing Termites (Isoptera: Macrotermitinae).

+ cite this

+ View Abstract

Marten A, Kaib M, and Brandl R

Journal of chemical ecology 35(5):572-9, 2009 May - Who cited this? | PubMed ID: 19399557 | Fulltext

A Randomized Multicentre Phase II Trial Comparing Adjuvant Therapy in Patients with Interferon Alpha-2b and 5-FU Alone or in Combination with Either External Radiation Treatment and Cisplatin (CapRI) or Radiation alone regarding Event-Free Survival - CapRI-2.

+ cite this

+ View Abstract

Märten A, Schmidt J, Ose J, Harig S, Abel U, Münter MW, Jäger D, Friess H, Mayerle J, Adler G, Seufferlein T, Gress T, Schmid R, and Büchler MW

BMC cancer 9:160, 2009 - Who cited this? | PubMed ID: 19470159 | Fulltext

An open label randomized multicentre phase IIIb trial comparing parenteral substitution versus best supportive nutritional care in subjects with pancreatic adenocarcinoma receiving 5-FU plus oxaliplatin as 2nd or higher line chemotherapy regarding clinical benefit - PANUSCO.

+ cite this

+ View Abstract

Märten A, Wente MN, Ose J, Büchler MW, Rötzer I, Decker-Baumann C, Karapanagiotou-Schenkel I, Harig S, Schmidt J, and Jäger D

BMC cancer 9:412, 2009 - Who cited this? | PubMed ID: 19943918 | Fulltext

Bortezomib is ineffective in an orthotopic mouse model of pancreatic adenocarcinoma.

+ cite this

+ View Abstract

Märten A, Zeiss N, Serba S, Mehrle S, von Lilienfeld-Toal M, and Schmidt J

Molecular cancer therapeutics 7(11):3624-31, 2008 Nov - Who cited this? | PubMed ID: 19001444 | Fulltext

Interferon-alpha Enhances Antitumor Effect of Chemotherapy in an Orthotopic Mouse Model for Pancreatic Adenocarcinoma.

+ cite this

+ View Abstract

Zhu Y, Tibensky I, Schmidt J, Ryschich E, and Märten A

Journal of immunotherapy (Hagerstown, Md. : 1997), 2008 Jul 2 - Who cited this? | PubMed ID: 18600184 | Fulltext

Immunotherapy of pancreatic carcinoma.

+ cite this

+ View Abstract

Märten A and Büchler MW

Current opinion in investigational drugs (London, England : 2000) 9(6):565-9, 2008 Jun - Who cited this? | PubMed ID: 18516755 | Fulltext

Immunotherapy of pancreatic carcinoma.

+ cite this

+ View Abstract

Märten A

Reviews on recent clinical trials 3(2):121-5, 2008 May - Who cited this? | PubMed ID: 18474022 | Fulltext

Transfection with CD40L induces tumour suppression by dendritic cell activation in an orthotopic mouse model of pancreatic adenocarcinoma.

+ cite this

+ View Abstract

Serba S, Schmidt J, Wentzensen N, Ryschich E, and Märten A

Gut 57(3):344-51, 2008 Mar - Who cited this? | PubMed ID: 17675324 | Fulltext

Real-time high-resolution compound imaging allows percutaneous initiation and surveillance in an orthotopic murine pancreatic cancer model.

+ cite this

+ View Abstract

Ziske C, Tiemann K, Schmidt T, Nagaraj S, Märten A, Schmitz V, Clarenbach R, Sauerbruch T, and Schmidt-Wolf IG

Pancreas 36(2):146-52, 2008 Mar - Who cited this? | PubMed ID: 18376305 | Fulltext

Enhancement of anti-tumor activity in vitro and in vivo by CD150 and SAP.

+ cite this

+ View Abstract

Mehrle S, Schmidt J, Büchler MW, Watzl C, and Märten A

Molecular immunology 45(3):796-804, 2008 Feb - Who cited this? | PubMed ID: 17692919 | Fulltext

Interferon-alpha in combination with chemotherapy has potent antiangiogenic properties in an orthotopic mouse model for pancreatic adenocarcinoma.

+ cite this

+ View Abstract

Zhu Y, Tibensky I, Schmidt J, Hackert T, Ryschich E, Jäger D, Büchler MW, and Märten A

Journal of immunotherapy (Hagerstown, Md. : 1997) 31(1):28-33, 2008 Jan - Who cited this? | PubMed ID: 18157009 | Fulltext

Interferon-alpha restitutes the chemosensitivity in pancreatic cancer.

+ cite this

+ View Abstract

Hoffmann K, Mehrle S, Schmidt J, Büchler MW, and Märten A

Anticancer research 28(3A):1499-507, 2008 - Who cited this? | PubMed ID: 18630504 | Fulltext

Effects of the high-affinity Peptide reversin 121 on multidrug resistance proteins in experimental pancreatic cancer.

+ cite this

+ View Abstract

Hoffmann K, Bekeredjian R, Schmidt J, Büchler MW, and Märten A

Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 29(6):351-8, 2008 - Who cited this? | PubMed ID: 19039261 | Fulltext

Intratumoural injection of the toll-like receptor-2/6 agonist 'macrophage-activating lipopeptide-2' in patients with pancreatic carcinoma: a phase I/II trial.

+ cite this

+ View Abstract

Schmidt J, Welsch T, Jäger D, Mühlradt PF, Büchler MW, and Märten A

British journal of cancer 97(5):598-604, 2007 Sep 3 - Who cited this? | PubMed ID: 17667928 | Fulltext

Effect of Flt3 ligand gene transfer in experimental pancreatic cancer.

+ cite this

+ View Abstract

Ryschich E, Huszty G, Wentzensen N, Schmidt E, Knaebel HP, Encke J, Märten A, Büchler MW, and Schmidt J

International journal of colorectal disease 22(2):215-23, 2007 Feb - Who cited this? | PubMed ID: 16528542 | Fulltext

Impact of interferon-alpha in combined chemoradioimmunotherapy for pancreatic adenocarcinoma (CapRI): first data from the immunomonitoring.

+ cite this

+ View Abstract

Schmidt J, Jäger D, Hoffmann K, Büchler MW, and Märten A

Journal of immunotherapy (Hagerstown, Md. : 1997) 30(1):108-15, 2007 Jan - Who cited this? | PubMed ID: 17198089 | Fulltext

Minimal size MIDGE vectors improve transgene expression in vivo.

+ cite this

+ View Abstract

Schakowski F, Gorschlüter M, Buttgereit P, Märten A, Lilienfeld-Toal MV, Junghans C, Schroff M, König-Merediz SA, Ziske C, Strehl J, Sauerbruch T, Wittig B, and Schmidt-Wolf IG

In vivo (Athens, Greece) 21(1):17-23, 2007 - Who cited this? | PubMed ID: 17354609 | Fulltext

Zoledronic acid has direct antiproliferative and antimetastatic effect on pancreatic carcinoma cells and acts as an antigen for delta2 gamma/delta T cells.

+ cite this

+ View Abstract

Märten A, Lilienfeld-Toal M, Büchler MW, and Schmidt J

Journal of immunotherapy (Hagerstown, Md. : 1997) 30(4):370-7, 2007 - Who cited this? | PubMed ID: 17457212 | Fulltext

Characterization of primary renal carcinoma cultures.

+ cite this

+ View Abstract

Sievers E, Dreimuller P, Haferkamp A, Schmidt-Wolf IG, Buchler MW, Schmidt J, and Marten A

Urologia internationalis 79(3):235-43, 2007 - Who cited this? | PubMed ID: 17940356 | Fulltext

Soluble MIC is elevated in the serum of patients with pancreatic carcinoma diminishing gammadelta T cell cytotoxicity.

+ cite this

+ View Abstract

Märten A, von Lilienfeld-Toal M, Büchler MW, and Schmidt J

International journal of cancer. Journal international du cancer 119(10):2359-65, 2006 Nov 15 - Who cited this? | PubMed ID: 16929491 | Fulltext

Immunomodulatory impact of interferon-alpha in combination with chemoradiation of pancreatic adenocarcinoma (CapRI).

+ cite this

+ View Abstract

Schmidt J, Patrut EM, Ma J, Jäger D, Knaebel HP, Büchler MW, and Märten A

Cancer immunology, immunotherapy : CII 55(11):1396-405, 2006 Nov - Who cited this? | PubMed ID: 16485127 | Fulltext

PankoMab: a potent new generation anti-tumour MUC1 antibody.

+ cite this

+ View Abstract

Danielczyk A, Stahn R, Faulstich D, Löffler A, Märten A, Karsten U, and Goletz S

Cancer immunology, immunotherapy : CII 55(11):1337-47, 2006 Nov - Who cited this? | PubMed ID: 16485130 | Fulltext

Habitat type predicts genetic population differentiation in freshwater invertebrates.

+ cite this

+ View Abstract

Marten A, Brändle M, and Brandl R

Molecular ecology 15(9):2643-51, 2006 Aug - Who cited this? | PubMed ID: 16842433 | Fulltext

Activating anti-CD40 antibodies induce tumour invasion by cytotoxic T-lymphocytes and inhibition of tumour growth in experimental liver cancer.

+ cite this

+ View Abstract

Ryschich E, Märten A, Schmidt E, Linnebacher M, Wentzensen N, Eisold S, Klar E, Büchler MW, and Schmidt J

European journal of cancer (Oxford, England : 1990) 42(7):981-7, 2006 May - Who cited this? | PubMed ID: 16564167 | Fulltext

Patient-derived dendritic cells transduced with an a-fetoprotein-encoding adenovirus and co-cultured with autologous cytokine-induced lymphocytes induce a specific and strong immune response against hepatocellular carcinoma cells.

+ cite this

+ View Abstract

González-Carmona MA, Märten A, Hoffmann P, Schneider C, Sievers E, Schmidt-Wolf IG, Sauerbruch T, and Caselmann WH

Liver international : official journal of the International Association for the Study of the Liver 26(3):369-79, 2006 Apr - Who cited this? | PubMed ID: 16584401 | Fulltext

Telomerase-specific T-cells kill pancreatic tumor cells in vitro and in vivo.

+ cite this

+ View Abstract

Schmidt J, Ryschich E, Sievers E, Schmidt-Wolf IG, Büchler MW, and Märten A

Cancer 106(4):759-64, 2006 Feb 15 - Who cited this? | PubMed ID: 16369992 | Fulltext

Release of iC3b from apoptotic tumor cells induces tolerance by binding to immature dendritic cells in vitro and in vivo.

+ cite this

+ View Abstract

Schmidt J, Klempp C, Büchler MW, and Märten A

Cancer immunology, immunotherapy : CII 55(1):31-8, 2006 Jan - Who cited this? | PubMed ID: 15891882 | Fulltext

Major combined electrolyte deficiency during therapy with low-dose cisplatin, 5-fluorouracil and interferon alpha: report on several cases and review of the literature [ISRCTN62866759].

+ cite this

+ View Abstract

Hoffmann K, Marten A, Lindel K, Fritz S, Jager D, Buchler MW, and Schmidt J

BMC cancer 6:128, 2006 - Who cited this? | PubMed ID: 16686958 | Fulltext

Telomerase-pulsed dendritic cells: preclinical results and outcome of a clinical phase I/II trial in patients with metastatic renal cell carcinoma.

+ cite this

+ View Abstract

Märten A, Sievers E, Albers P, Müller S, Franchy C, von Ruecker A, Strunk H, Schild HH, Schmiedel A, Sommer T, Sauerbruch T, and Schmidt-Wolf IG

German medical science 4:Doc02, 2006 - Who cited this? | PubMed ID: 19675693 | Fulltext

Coculture with dendritic cells promotes proliferation but not cytotoxic activity of gamma/delta T cells.

+ cite this

+ View Abstract

von Lilienfeld-Toal M, Sievers E, Bodemüller V, Mihailescu C, Märten A, Gorschlüter M, and Schmidt-Wolf IG

Immunology letters 99(1):103-8, 2005 Jun 15 - Who cited this? | PubMed ID: 15894118 | Fulltext

Titan's atmospheric temperatures, winds, and composition.

+ cite this

+ View Abstract

Flasar FM, Achterberg RK, Conrath BJ, Gierasch PJ, Kunde VG, Nixon CA, Bjoraker GL, Jennings DE, Romani PN, Simon-Miller AA, Bézard B, Coustenis A, Irwin PG, Teanby NA, Brasunas J, Pearl JC,

(show remaining authors)

Science (New York, N.Y.) 308(5724):975-8, 2005 May 13 - Who cited this? | PubMed ID: 15894528 | Fulltext

Synergistic effects of interferon-alpha in combination with chemoradiation on human pancreatic adenocarcinoma.

+ cite this

+ View Abstract

Ma JH, Patrut E, Schmidt J, Knaebel HP, Büchler MW, and Märten A

World journal of gastroenterology : WJG 11(10):1521, 2005 Mar 14 - Who cited this? | PubMed ID: 15770730 | Fulltext

Temperatures, winds, and composition in the saturnian system.

+ cite this

+ View Abstract

Flasar FM, Achterberg RK, Conrath BJ, Pearl JC, Bjoraker GL, Jennings DE, Romani PN, Simon-Miller AA, Kunde VG, Nixon CA, Bézard B, Orton GS, Spilker LJ, Spencer JR, Irwin PG, Teanby NA,

(show remaining authors)

Science (New York, N.Y.) 307(5713):1247-51, 2005 Feb 25 - Who cited this? | PubMed ID: 15618486 | Fulltext

SAP and SLAM expression in anti-CD3 activated lymphocytes correlates with cytotoxic activity.

+ cite this

+ View Abstract

Mehrle S, Frank S, Schmidt J, Schmidt-Wolf IG, and Märten A

Immunology and cell biology 83(1):33-9, 2005 Feb - Who cited this? | PubMed ID: 15661039 | Fulltext

Phase III trial of postoperative cisplatin, interferon alpha-2b, and 5-FU combined with external radiation treatment versus 5-FU alone for patients with resected pancreatic adenocarcinoma -- CapRI: study protocol [ISRCTN62866759].

+ cite this

+ View Abstract

Knaebel HP, Märten A, Schmidt J, Hoffmann K, Seiler C, Lindel K, Schmitz-Winnenthal H, Fritz S, Herrmann T, Goldschmidt H, Krempien R, Mansmann U, Debus J, Diehl V, and Büchler MW

BMC cancer 5(1):37, 2005 - Who cited this? | PubMed ID: 15826316 | Fulltext

Dendritic cells reduce number and function of CD4+CD25+ cells in cytokine-induced killer cells derived from patients with pancreatic carcinoma.

+ cite this

+ View Abstract

Schmidt J, Eisold S, Büchler MW, and Märten A

Cancer immunology, immunotherapy : CII 53(11):1018-26, 2004 Nov - Who cited this? | PubMed ID: 15185013 | Fulltext

Jupiter's atmospheric composition from the Cassini thermal infrared spectroscopy experiment.

+ cite this

+ View Abstract

Kunde VG, Flasar FM, Jennings DE, Bézard B, Strobel DF, Conrath BJ, Nixon CA, Bjoraker GL, Romani PN, Achterberg RK, Simon-Miller AA, Irwin P, Brasunas JC, Pearl JC, Smith MD, Orton GS,

(show remaining authors)

Science (New York, N.Y.) 305(5690):1582-6, 2004 Sep 10 - Who cited this? | PubMed ID: 15319491 | Fulltext

Retroviral IFN-alpha gene transfer combined with gemcitabine acts synergistically via cell cycle alteration in human pancreatic carcinoma cells implanted orthotopically in nude mice.

+ cite this

+ View Abstract

Ziske C, Nagaraj S, Märten A, Gorschlüter M, Strehl J, Sauerbruch T, Abraham NG, and Schmidt-Wolf IG

Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research 24(8):490-6, 2004 Aug - Who cited this? | PubMed ID: 15320962 | Fulltext

Tumour suppression induced by the macrophage activating lipopeptide MALP-2 in an ultrasound guided pancreatic carcinoma mouse model.

+ cite this

+ View Abstract

Schneider C, Schmidt T, Ziske C, Tiemann K, Lee KM, Uhlinsky V, Behrens P, Sauerbruch T, Schmidt-Wolf IG, Mühlradt PF, Schmidt J, and Märten A

Gut 53(3):355-61, 2004 Mar - Who cited this? | PubMed ID: 14960515 | Fulltext

An intense stratospheric jet on Jupiter.

+ cite this

+ View Abstract

Flasar FM, Kunde VG, Achterberg RK, Conrath BJ, Simon-Miller AA, Nixon CA, Gierasch PJ, Romani PN, Bézard B, Irwin P, Bjoraker GL, Brasunas JC, Jennings DE, Pearl JC, Smith MD, Orton GS,

(show remaining authors)

Nature 427(6970):132-5, 2004 Jan 8 - Who cited this? | PubMed ID: 14712270 | Fulltext

Telomerase pulsed dendritic cells for immunotherapy for renal cell carcinoma.

+ cite this

+ View Abstract

Sievers E, Albers P, Schmidt-Wolf IG, and Märten A

The Journal of urology 171(1):114-9, 2004 Jan - Who cited this? | PubMed ID: 14665857 | Fulltext

Intratumoral immunization with tumor RNA-pulsed dendritic cells confers antitumor immunity in a C57BL/6 pancreatic murine tumor model.

+ cite this

+ View Abstract

Schmidt T, Ziske C, Märten A, Endres S, Tiemann K, Schmitz V, Gorschlüter M, Schneider C, Sauerbruch T, and Schmidt-Wolf IG

Cancer research 63(24):8962, 2003 Dec 15 - Who cited this? | PubMed ID: 14695214 | Fulltext

Cellular immunotherapy after autologous hematopoietic stem cell transplantation: experimental strategies and clinical experiences.

+ cite this

+ View Abstract

Abken H, Hombach A, Reinhard G, Märten A, Schlimper C, Glasmacher A, Bieber T, and Schmidt-Wolf IG

Leukemia & lymphoma 44(4):583-92, 2003 Apr - Who cited this? | PubMed ID: 12769334 | Fulltext

Allogeneic dendritic cells fused with tumor cells: preclinical results and outcome of a clinical phase I/II trial in patients with metastatic renal cell carcinoma.

+ cite this

+ View Abstract

Märten A, Renoth S, Heinicke T, Albers P, Pauli A, Mey U, Caspari R, Flieger D, Hanfland P, Von Ruecker A, Eis-Hübinger AM, Müller S, Schwaner I, Lohmann U, Heylmann G, Sauerbruch T,

(show remaining authors)

Human gene therapy 14(5):483-94, 2003 Mar 20 - Who cited this? | PubMed ID: 12691613 | Fulltext

Search Google Scholar for Märten A

Join Labmeeting

Organize and search your PDF collection
Collect papers
Search millions of papers
Keep up to date with paper alerts
Read your papers from anywhere
Recommend papers to colleagues
Manage your lab

Labmeeting is a web service for researchers. Sign up with your academic email address.

Individuals or corporations not affiliated with an academic institution can request a trial subscription.